Name Dr Jan Martin
Job Title

Deputy Head of School and Principal Lecturer (PSRB)

Faculty Faculty of Science and Engineering
School School of Sciences
Subject(s) Oncology
Tel 01902 321154
Email j.martin@wlv.ac.uk

Biomedical science

I graduated from The Queen’s University of Belfast with a BSc (Hons) Biochemistry degree in 1987.

I then joined the Faculty of Medicine at The Queen’s University of Belfast where I spent three years studying for a PhD in Oncology where my research focussed on modulation of growth factor and steroid hormone receptor expression in human breast cancer cells.

Following completion of my PhD, I moved to the University of Liverpool in 1990, where I carried out three years of Post-Doctoral research investigating the role of monocytes and macrophages in tumour cell killing.

I then took up the role of lecturer in Biomedical Science at the University of Wolverhampton in 1993 and Senior lecturer in 1998. I then took on a role as Principal Lecturer and Placement Manager before my current role as Principal Lecturer for Accreditation and Development (PSRB) and Deputising for Head of School.

Oncology

Continuing Professional Development

Continuing Professional Development – The European Perspective

I am interested in the approaches to Continuing Professional Development (CPD) for Biomedical Scientists in different European Countries. There are different requirements in different European countries for how continued registration/licence is linked to CPD and the requirements for certain amounts and types of CPD and for CPD activities to meet specified accreditation criteria. As there is a spectrum of approaches to CPD within different European countries

I was awarded a grant for 100,000 Euros from the European Commission Leonardo Partnership funding stream for the following project ‘Enhance IT - Enhancing Hospital Laboratory Standards for CPD: A Quality Improvement Toolkit’

 

Continuing Professional Development – What is the Impact?

I am also interested in the impact of Continuing Professional Development. Although the purposes of CPD are clearly defined by most professional bodies, I am currently ascertaining if CPD activities are actually effective in achieving the overall specified purpose of CPD and how/if this can be effectively measured. 

Chartered Biologist

Chartered Scientist

Fellow of the Higher Education Academy

Fellow of the Institute of Biomedical Science

Fellow of the Society of Biology

64. Martin J, Gasljevic V, Šálek T et al (2015) Fifth Transnational Meeting of a European Project to Enhance Hospital Laboratory Standards for Biomedical Scientist's Continuing Professional Development The Biomedical Scientist 59 (6) 330-331

 

63.   Martin J, Buttigieg D Silhavik J et al (2015) Transnational Evaluation of a New Continuing Professional Development Activity for Biomedical Scientists Based on the International Organisation for Standardisation for Medical Laboratories ISO 15189. American Journal of Educational Research in press

 

62.   Martin J Adkins A, Bennett T, Rice K and Taylor Y. (2015) European Project to Enhance Laboratory Standards for        Biomedical Scientist CPD: Fourth Transnational Meeting. The Biomedical Scientist 59 (3) 154-156

 

61. Martin J, Buttigieg D Silhavik J et al (2014k) Enhance It - Enhancing Hospital Laboratory Standards for Continuing Professional Development: Transnational Evaluation of a Novel CPD Activity for Biomedical Scientists. American Journal of Educational Research vol. 2, no. 11, 1110-1114. doi: 10.12691/education-2-11-18.

 

60.   Smith S, Ganesan R and Martin J (2014j)  Flipping the postgraduate classroom – is it just another pedagogic fad? Medical Education – submitted

 

 59.  Martin J, Gasljevic V, Šálek T, et al (2015a) Comparison of Approaches and    Measurement of Continuing Professional Development for Specialists in Laboratory      Medicine within Four European Countries. Clinical Chemistry and Laboratory     Medicine        53(1): 35–44

 

 58.  Smith S and Martin J (2014i) Practitioner Capability: supporting critical  reflection during      work-based placement – a Pilot study. Higher education, Skills and Work-based learning,           Vol. 4 (3) pp. 284 - 300

 

57. Martin J (2014h) European Project to Enhance Laboratory Standards for          Biomedical Scientist CPD: Third Transnational Meeting. The Biomedical Scientist 58 (10) 550-551

 

56.   Martin J (2014g) Service User Involvement in BSc (Hons) Applied Biomedical Science degrees The Biomedical Scientist 58 (12) 668-669

 

55.   Martin J, Adkins A, Bennett T, Rice K and Taylor Y. (2014f) European Project to Enhance Standards for Biomedical Scientist CPD: Developing a Quality   Improvement Toolkit. The Biomedical Scientist – (6) 321-323

 

54. Martin J, Adkins A, Rice K and Taylor, Y (2014e) Undergraduate Biomedical Science Curriculum: Keeping it Relevant to Current Laboratory Practice. The Biomedical Scientist. 58 (5) 266-267

 

53.   Martin J (2014d) Enhancing Laboratory Standards for Continuing Professional Development: a Transnational Project The Biomedical Scientist 58 (5) 262-265

 

52.   Martin J (2014b) European Project to Enhance Continuing Professional Development for Biomedical Scientists. The Biomedical Scientist  58 (3) 155

 

51.   Martin J (2014a) Education, Training and Management at Congress: Developing good practice in pre-registration training. The Biomedical Scientist 58 (2) 76

 

50.   Martin J, Elliott, Y and Johnson E (2014c) Training for New Training Officers: A          Combined Aston, Coventry and Wolverhampton Universities Event The Biomedical Scientist 58 (3) 150-153

 

49.   Martin, J (2013f) A European Project to Enhance Hospital Laboratory    Standards for Biomedical Scientists Continuing Professional Development by        Establishing a Quality Improvement Toolkit and an Online Community of        Practice.          National Association of Primary Care Review Winter 2013/14, 29-30

 

48.   Martin J, Elliott, Y and Johnson E(2013e) Placement Student Workshops: A     Combined Approach by Aston, Coventry and Wolverhampton Universities. The   Biomedical Scientist 57 (11) 672-674

 

47.   Smith S and Martin J (2013)Practitioner capability: supporting critical   reflection – a pilot study. The Biomedical Scientist 57 (10): 608-609

 

46.   Martin, J (2013d) Combined Aston, Coventry and Wolverhampton Meeting:     Training The Trainers Annual Placement Feedback:  The Biomedical Scientist 57      (9): 548-551

 

45.   Adkins, A.E., Taylor, Y. and Martin, J.HJ (2013c) Biomedical Science Placement Provision within the West Midlands South Region: Status Quo? The Biomedical Scientist 57 (7) 404-405

 

44.   Martin J, (2013b) Training The Trainers: Combined Aston, Coventry and         Wolverhampton Universities Portfolio Peer Review. The Biomedical Scientist 57 (6) 348-349

 

43.   Martin J, (2013a) A Transnational Project to Develop Good Practice in Preregistration Training of Biomedical Scientists: UK and Malta. The Biomedical Scientist57 (1) 42-44

 

42.   Blann A, Dalton J and Martin J (2012d) Putting a Price on Pathology. Health Service Journal. 6th September 2012. Available at      <http://www.hsj.co.uk/resource-centre/best-practice/qipp-resources/putting-a-         price-on-pathology/5048530.article>

 

41.   Martin, J (2012c) Training The Trainers Annual Placement Feedback:    Combined Aston, Coventry and Wolverhampton Meeting. The Biomedical          Scientist 56 (9): 563-565

 

40.   Martin J, (2012a) Developing Good Practice in Preregistration Training: a UK/ Malta Transnational project. The Biomedical Scientist 56 (1): 46-47

 

39.   Martin JHJ (2011c) Training The Trainers: A Combined One Day Meeting The Biomedical Scientist 55 (4): 258-261

 

38.   Martin JHJ (2011b) Placement Laboratories: A Combined Approach to Auditing in the West Midlands Region. The Biomedical Scientist 55 (3): 194-195

 

37.   Martin JHJ (2010e) Sharing Good Practice: a one-day meeting for Placement Facilitators. The Biomedical Scientist 54 (12): 874-875

 

36.   Martin JHJ (2010d) Keeping the Undergraduate Biomedical Science Curriculum Relevant to Current Practice: a one day meeting The Biomedical      Scientist 54 (9): 656-657

 

35.   Martin JHJ (2010c) Training The Trainers: A Transnational Approach The        Biomedical Scientist 54 (8): 572

 

34.   Martin JHJ (2010b) West Midlands Regional Training Event:  a one-day           meeting The Biomedical Scientist 54 (7): 500-501

 

33.   Martin JHJ (2010a) West Midlands training officers Specialist Portfolio workshops: a one-day meeting The Biomedical Scientist 54 (4): 278-279

 

32.   Martin JHJ (2009) West Midlands training officers workshops: a one-day meeting The Biomedical Scientist 53 (11): 959-960

 

31.Martin J, (2012b) It doesn’t matter where I sit……… does it? The Effect of Changing   Classroom Seating Position on Student Performance and Motivation Factors, Online Educational Research Journal 3:4

 

30. Lahiri M and Martin JHJ (2009) Nitric oxide decreases motility and increases adhesion in human breast cancer cells. Oncology Reports 21: 275-281

 

29.Martin JHJ, Crotty S and Nelson PN (2007) Phytoestrogens………Perpetrators or Protectors? Future Oncology  3: 307-318

 

28 Martin JHJ, Crotty S, Warren P and Nelson PN (2007)  Does an apple a day keep the doctor away because a phytoestrogen a day keeps the virus at bay? A review of the anti-viral properties of phytoestrogens. Phytochemistry  68: 266-274

 

27 Ejthadi HD, Martin JH, Jeung G, Roden DA, Lahiri M, Warren P, Murray PG and Nelson PN (2005) A Novel Multiplex RT-PCR System Detects Human          Endogenous Retrovirus-K in Breast Cancer. Arch Virol 150: 177-184

26 Lahiri M and Martin JHJ (2004) Reduced Expression of Endothelial and     Inducible Nitric         Oxide Synthase in a Multi-drug Resistant Variant of the MCF-7          Human Breast Cancer Cell    Line. Oncology Reports 12: 1007-1011

 

25 P.N. Nelson, P. Hooley, D. Roden, H. Davari Ejtehadi, P. Rylance, P. Warren, J. Martin & P.G.   Murray (2004)  Human Endogenous Retroviruses: Transposable Elements with Potential?      Clin Exp Immunol 138: 1-9

 

24.Martin JHJ, Symonds A and Chohan S (2003) Down-Regulation of Nitric Oxide Production by Droloxifene and Toremifene in Human Breast Cancer           Cells. Oncology Reports 10: 979-84

 

23.Nelson PN, Davari Ejtehadi H, Carnegie P, Roden D, Martin J, Rowland-Jones S, Hooley P, Astley J and Murray PG (2003) Demystified….Human Endogenous Retroviruses. J Clin Path; Mol Path 56, 11-18.

 

22.Smyth M, Pettitt T, Symonds A and Martin J (2003) Identification of the Pocket Factors in a Picornavirus. ArchivesVirol 148: 1225-33.

21.Smyth MS, Symonds A, Brazinova S and Martin JHJ (2002) Bovine Enterovirus as an Oncolytic Virus: Foetal Calf Serum Facilitates its    infection of Human Cells. Int. J. Mol. Med. 10, 49-53

 

20.Martin, J.H.J. Symonds A, and  Chohan S. (2002) Down-Regulation of Nitric Oxide Production by Droloxifene and Toremifene in Human Breast CancerCells: Interferon Alpha has No Further Effect.  The Internet Journal of  Oncology. 1, (2).

 

19.Smyth, M.S.and Martin, JHJ (2002) Picornavirus Uncoating.  J Clin Path; Mol     Path  55: 214-219

18.Martin JHJ and Symonds A (2002) Synergistic Antitumour Effect of a Combination of Toremifene and Interferon Alpha on ZR-75-1 Human Breast Cancer Cells: Dependence on Interferon Alpha Subtype. Oncology Reports 9, 379-382

 

17.Smyth, M.S. & Martin, J.H.J. (2001)Structural, biochemical and electrostatic basis of serotype specificity in bovine enteroviruses.Archives Virol. 146, 347-355

 

16.Martin, J.H.J. Alalami, O. and Yaqoob, F (2000) Differential effects of retinoids on nitric oxide production by promonocytic U937 cells and ZR-75-1 human breast cancer cells. Oncology Rep. 7, 219-223

 

15.Smyth, M.S.and Martin, J.H.J. (2000) X-ray crystallography. J Clin Path; Mol Path  53, 8-14

 

14.Smyth, M., Trudgett, A., Martin, J., Hoey, E. and Martin S. (2000) Conformational changes during proteolytic processing of picornavirus capsid      proteins.        Archives Virol.  145, 1473-1479

 

13    Martin, J.H.J., Begum, S., Alalami, O., Harrison, A. and Scott, K. (2000) Endothelial Nitric Oxide Synthase: Correlation with histologic grade, lymph        node status and estrogen receptor expression in human breast cancer.  Tumor Biol. 21, 90-97

 

12.Jamil, I., Symonds, A., Lynch, S., Alalami, O., Smyth, M. and Martin J. (1999) Divergenteffects of paracetamol on reactive oxygen intermediate and reactive nitrogen intermediate production by U937 cells Int. J. Mol. Med. 4, 309-312

 

11. Martin, J.H.J. Alalami,O. & van den Berg, H.W.(1999) Reduced expression of endothelial and inducible nitric oxide synthase in a human breast cancer cell line which has acquired estrogen independence.Cancer Letts 144, 65-74

 

10.Alalami, O., Sammons, J., Martin, J.H.J. and Hassan, H.T.(1998)Divergent Effect of Taxol on Proliferation, Apoptosis and Nitric Oxide Production in MHH225 CD34 Positive and U937 CD34 Negative Human Leukaemia Cells.Leukemia Res., 22, 939-945

 

  9. Alalami, O. and Martin, J.H.J. (1998) ZR-75-1 Human Breast Cancer Cells Expression of         Inducible Nitric Oxide Synthase and Effect of Tamoxifen and Phorbol Ester on Nitric     Oxide Production Cancer Letts., 123, 99-105

 

  8. Davies, J.I., Smyth, M.S. and Martin, J.H.J. (1997) Automated Reticulocyte Counting. Evaluation of the Coulter STKS Haematology Analyser Reticulocyte Counting Function Clin      and Lab Haematol. 19, 89 -92

 

  7. Martin, J.H.J. and Alalami, O. (1996) Tamoxifen inhibits phorbol ester-induced reactive         nitrogen intermediate production by U937 cells. Oncology Rep. 3, 935-  937

 

6. Martin, J.H.J. and Edwards, S.W. (1994) Interferon-gamma enhances     monocyte      cytotoxicity via enhanced reactive oxygen intermediate   production.  Absence of  an effect on macrophage cytotoxicity is due to failure to enhance reactive nitrogen intermediate production. Immunology, 81, 592-597

 

5. van den berg, H.W., Lynch, M and Martin, J.H.J. (1993) The relationship between affinity of progestins and anti-progestins for the progesterone receptor        in       breast cancer cells (ZR-PR-LT) and ability to down-regulate the receptor: evidence for heterospecific receptor modulation via the glucocorticoid receptor.     Eur. J. Cancer, 29, 1771-1775

 

4. Martin, J.H.J. and Edwards, S.W. (1993) Changes in mechanisms of       monocyte/macrophage mediated cytotoxicity during culture.  Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity whereas reactive       nitrogen intermediates are employed by macrophages in tumour cell killing.  J. Immunol., 150, 3478-3486

 

3. Martin, J.H.J., McKibben, B., Lynch, M and van den Berg, H.W. (1991) Modulation by oestrogen and progestins/antiprogestins of alpha interferon receptor expression in human breast cancer cells. Eur. J. Cancer, 27, 143-146

 

2. van den Berg, H.W., Martin, J. and Lynch, M. (1990) High progesterone   receptorconcentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen-free conditions.  Br. J. Cancer, 61, 504-507

 

1.       van den Berg, H.W., Lynch, M., Martin, J., Nelson, J., Dickson, G.R. and        Crockard, A.D. (1989) Characterisation of a tamoxifen-resistant variant of the   ZR-75-1 human breast cancer cell line (ZR-75-9a1) and stability of the resistant phenotype. Br. J. Cancer, 59, 522-526